Author

Vera Helena Jepsen

Deutsches Konsortium für Translationale KrebsforschungORCID 0000-0003-4174-7568Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Developmental Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

Carla‐Johanna Kath· 2 shared Gesine KögleriD· 2 shared Nadine RücheliD· 2 shared Rigveda BhaveiD· 2 shared Ute FischeriD· 2 shared Aleksandra A. PandyraiD· 1 shared Andrea HäneliD· 1 shared Arndt BorkhardtiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersDevelopmental Biology

Carla‐Johanna Kath

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Developmental BiologyScientific ReportsPeer-reviewedDec 18, 2025

Serum-free differentiation platform for the generation of B lymphocytes and natural killer cells from human CD34+ cord blood progenitors

Rigveda Bhave, Carla‐Johanna Kath, Nadine Rüchel…·Gesine Kögler

This paper introduces a serum-free co-culture system using human bone marrow stromal cells to differentiate cord blood CD34+ progenitors into B and NK cells, offering a more physiologically relevant model for hematopoiesis research.

2 citations

humanexperimental assay

𝕏 PostBluesky

Cancer BiologyHemaSpherePeer-reviewedApr 1, 2025

Linker histone H1-0 is a specific mediator of the repressive ETV6::RUNX1 transcriptional landscape

Vera Helena Jepsen, Andrea Hänel, Daniel J. Picard…·Ute Fischer

This study identifies H1-0 as a mediator of ETV6::RUNX1-induced quiescence in BCP-ALL preleukemic cells and suggests HDACi treatment as a potential therapeutic approach.

4 citations

humanbulk RNA-seq

𝕏 PostBluesky